Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1613373-40-2 | 1-(4-Bromo-3,5-dimethylphenyl)-5,5-dimethylimidazolidine-2,4-dione | C13H15BrN2O2 |
| 1613373-48-0 | 2-[4-(Trifluoromethoxy)phenyl]-8-(vinylsulfonyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one | C16H16F3N3O4S |
| 1613393-51-3 | (3aR,5S)-5-Methyl-3,3a,4,5-tetrahydro-7H-pyrano[3,4-c][1,2]oxazole | C7H11NO2 |
| 1613406-18-0 | 3,10-Dihydro-3-phenylpyrazolo[4,3-a]carbazole | C19H13N3 |
| 1613439-62-5 | 1-[4-(5'-Chloro-3,5-dimethyl[2,4'-bipyridin]-2'-yl)-1-piperazinyl]-3-(methylsulfonyl)-1-propanone hydrochloride (1:1) | C20H25ClN4O3S.HCl |
| 1613482-41-9 | Pyrrolidine Related Compound 12 | C10H18N2O4 |
| 1613506-26-5 | (3beta,4beta,16alpha,21beta,22alpha)-22-(acetyloxy)-16,23,28-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-Glucopyranosiduronic acid | C49H76O19 |
| 1613506-28-7 | (3beta,4alpha,16alpha,21beta,22alpha)-28-(Acetyloxy)-16,22,23-trihydroxy-21-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]olean-12-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranosiduronic acid | C49H76O19 |
| 1613527-65-3 | Mogroside II A | C42H72O14 |
| 1613695-14-9 | 2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3,5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-1H-benzimidazole | C28H33ClN4O3 |
| 1613705-06-8 | 2,5-Dihydro-2,5-dioctyl-3,6-bis[5-(trimethylstannyl)-2-thienyl]pyrrolo[3,4-c]pyrrole-1,4-dione | C36H56N2O2S2Sn2 |
| 1613710-01-2 | 3-(2,4-Dimethoxyphenyl)-4-(3-thienyl)-1H-pyrrolo[2,3-b]pyridine | C19H16N2O2S |
| 1613724-42-7 | 5,13-Dihydro-4,5,13-trimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-naphtho[2,3-e]pyrimido[5,4-b][1,4]diazepin-6-one | C26H28N8O |
| 1613751-69-1 | 2-Chloropyrrolo[2,1-f][1,2,4]triazin-4(1H)-one | C6H4ClN3O |
| 1614253-96-1 | 4,9-Dibromo-2,7-bis(2-butyloctyl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone | C38H52Br2N2O4 |
| 1614255-90-1 | Cefixime EP Impurity A | C16H17N5O8S2 |
| 1614255-93-4 | 2-[[(Z)-[1-(2-Amino-4-thiazolyl)-2-oxo-2-[[[(2R,5R)-1,2,5,7-tetrahydro-5-methyl-7-oxo-4H-furo[3,4-d][1,3]thiazin-2-yl]methyl]amino]ethylidene]amino]oxy]acetic acid | C15H17N5O6S2 |
| 1615212-05-9 | 5-Bromo-1-chloro-2-iodo-3-methoxybenzene | C7H5BrClIO |
| 1616113-45-1 | 8,8'-(1'-Acetylspiro[9H-fluorene-9,4'-piperidine]-2,7-diyl)bis[2,6-anhydro-7,8-dideoxy-D-glycero-D-manno-oct-7-ynitol] | C35H39NO11 |
| 1616115-25-3 | Dichloroiodoplumbate(1-) hydrogen compd. With methanimidamide (1:1:1) | CH4N2.PbCl2I.H |
| 1616340-68-1 | 5-[[[(2,4-Difluorophenyl)methyl]amino]carbonyl]-1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2-pyridinecarboxylic acid methyl ester | C20H22F2N2O7 |
| 1616340-94-3 | (2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide | C22H20F3N3O5 |
| 1616342-45-0 | (2R,5S,13aR)-2,3,4,5,7,9,13,13a-Octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid | C15H16N2O6 |
| 1616391-65-1 | N-[(2S)-3-(3,4-Dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-6-(3-oxetanylamino)-4-pyrimidinecarboxamide | C20H25N5O3 |
| 1616391-87-7 | 2-(Cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-4-pyridinecarboxamide | C22H28N4O2 |
| 1616493-44-7 | Tucidinostat | C22H19FN4O2 |
| 1616499-37-6 | 2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole | C26H16ClN3 |
| 1616592-59-6 | Erythrinin D | C21H18O6 |
| 1616592-60-9 | Erythrinin F | C20H18O7 |
| 1616592-61-0 | Erythrinin G | C20H18O6 |
| 1616592-62-1 | Erythrinin H | C17H12O7 |
| 1616607-88-5 | 2-(2-Bromophenyl)-9-phenyl-9H-carbazole | C24H16BrN |
| 1616632-77-9 | 2,4,6,7,8,9-Hexahydro-4-[(2-methylphenyl)methyl]-7-(phenylmethyl)imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one | C24H26N4O |
| 1616668-55-3 | Tetrazine-NHS Ester | C14H11N5O4 |
| 1616703-93-5 | Ticagrelor EP Impurity C | C25H30F2N6O5S |
| 1616760-97-4 | 2-Chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C13H18ClN5 |
| 1616761-00-2 | (3R,4R)-3-[(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-beta-oxo-1-piperidinepropanenitrile | C16H19ClN6O |
| 1616761-01-3 | (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanoic acid methyl ester | C17H23N5O3 |
| 1616967-26-0 | Formoterol EP Impurity E | C20H26N2O4 |
| 1616979-93-1 | tert-Butylbis(3,5-di-tert-butylphenyl)phosphine | C32H51P |
| 1616983-07-3 | 4,6-Dibromobenzene-1,2,3,5-d4 | C6D4Br2 |
| 1618083-32-1 | 3-Amino-4-(aminomethyl)benzoic acid methyl ester | C9H12N2O2 |
| 1618107-00-8 | 2-Chloro-4-(2-dibenzofuranyl)-6-phenyl-1,3,5-triazine | C21H12ClN3O |
| 1618657-31-0 | Ezetimibe Impurity 9 | C18H17FO4 |
| 1619934-76-7 | Ethyl 1-(4-methoxyphenyl)-7a-morpholino-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-3a,4,5,6,7,7a-hexahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C31H37N5O6 |
| 1619967-09-7 | (3,3'-Difluoro-[2,2'-bithiophene]-5,5'-diyl)bis(trimethylstannane) | C14H20F2S2Sn2 |
| 1619994-68-1 | 1-[1-[2-(Methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]ethanone | C20H21NO4S |
| 1619994-69-2 | Ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate | C17H20N6O4S |
| 1620056-83-8 | 2-(5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic acid | C10H7F5N2O2 |
| 1620097-04-2 | N-[(3R)-3-[[(1,1-Dimethylethoxy)carbonyl]amino]-1-oxobutyl]-N-(phenylmethyl)glycine methyl ester | C19H28N2O5 |